Main Page

Our research group is doing cardiovascular and molecular epidemiology with a special focus on metabolic disturbances such as obesity and insulin resistance and their role in the development of subclinical and clinical cardiovascular disease.

Much of our research is translational, trying to bridge molecular biology and clinical medicine using large-scale platforms for genomics, transcriptomics, proteomics and metabolomics.

Our ambition is to be an international, vibrant and creative research environment with many exciting projects within large-scale genetic and biomarker projects. Our research is projected to lead to new important insights of disease mechanisms, which in turn can facilitate development of new treatments of these diseases, as well as to new biomarkers of disease for improved risk prediction and prognostication.